News & Events Press Releases Events & Presentations Year None20212020201920182017 06.09 2021 Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) 06.07 2021 Translate Bio Achieves Manufacturing Milestone Related to Influenza mRNA Vaccine Program 05.24 2021 Translate Bio to Participate in Upcoming Investor Conferences 05.18 2021 Translate Bio Presents Preclinical Results in Primary Ciliary Dyskinesia (PCD) at American Thoracic Society (ATS) 2021 International Conference 05.06 2021 Translate Bio Announces First Quarter 2021 Financial Results and Provides Corporate Update 05.05 2021 Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) 04.28 2021 Translate Bio to Present at the 7th Annual Truist Securities Life Sciences Summit 04.20 2021 Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) 04.19 2021 Translate Bio Announces Publication of Preclinical Results of COVID-19 mRNA Vaccine Candidate MRT5500 in npj Vaccines 04.19 2021 Translate Bio Announces Key Leadership Additions and Promotions Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 20 Presentations Corporate Presentation 15.6 MB Upcoming Events 06.22 2021 2:00 PM EDT SVB Leerink 2nd Annual CybeRx Series: Vaccine Forum 07.15 2021 1:00 PM EDT William Blair Biotech Focus Virtual Conference
